Drug Profile


Alternative Names: NPS-1776

Latest Information Update: 25 Jun 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NPS Pharmaceuticals
  • Class Amides; Antiepileptic drugs; Antimigraines; Neuroprotectants; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Bipolar disorders; CNS disorders; Epilepsy; Migraine

Most Recent Events

  • 25 Jan 2005 Discontinued - Phase-II for Migraine in United Kingdom (PO)
  • 12 Oct 2004 Clinical data from a media release have been added to the adverse events and pharmacokinetics sections
  • 08 Jun 2004 Discontinued - Phase-I for Epilepsy in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top